BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wagner A, Weinberger B. Vaccines to Prevent Infectious Diseases in the Older Population: Immunological Challenges and Future Perspectives. Front Immunol 2020;11:717. [PMID: 32391017 DOI: 10.3389/fimmu.2020.00717] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Dijkstra JM, Hashimoto K. Expected immune recognition of COVID-19 virus by memory from earlier infections with common coronaviruses in a large part of the world population. F1000Res 2020;9:285. [PMID: 32595955 DOI: 10.12688/f1000research.23458.2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
2 Fulop T, Larbi A, Pawelec G, Cohen AA, Provost G, Khalil A, Lacombe G, Rodrigues S, Desroches M, Hirokawa K, Franceschi C, Witkowski JM. Immunosenescence and Altered Vaccine Efficiency in Older Subjects: A Myth Difficult to Change. Vaccines 2022;10:607. [DOI: 10.3390/vaccines10040607] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Levine MM, Abdullah S, Arabi YM, Darko DM, Durbin AP, Estrada V, Jamrozik E, Kremsner PG, Lagos R, Pitisuttithum P, Plotkin SA, Sauerwein R, Shi SL, Sommerfelt H, Subbarao K, Treanor JJ, Vrati S, King D, Balasingam S, Weller C, Aguilar AO, Cassetti MC, Krause PR, Restrepo AMH. Viewpoint of a WHO Advisory Group Tasked to Consider Establishing a Closely-monitored Challenge Model of Coronavirus Disease 2019 (COVID-19) in Healthy Volunteers. Clin Infect Dis 2021;72:2035-41. [PMID: 32857836 DOI: 10.1093/cid/ciaa1290] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Sarfraz A, Sarfraz Z, Sarfraz M, Abdul Razzack A, Bano S, Singh Makkar S, Thevuthasan S, Paul T, Khawar Sana M, Azeem N, Felix M, Cherrez-Ojeda I. Industry 4.0 Technologies for the Manufacturing and Distribution of COVID-19 Vaccines. J Prim Care Community Health 2022;13:21501319211068638. [PMID: 34984932 DOI: 10.1177/21501319211068638] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Proctor RA. Have We Outlived the Concept of Commensalism for Staphylococcus aureus? Clin Infect Dis 2021;73:e267-9. [PMID: 32971535 DOI: 10.1093/cid/ciaa1431] [Reference Citation Analysis]
6 Weight CM, Jochems SP, Adler H, Ferreira DM, Brown JS, Heyderman RS. Insights Into the Effects of Mucosal Epithelial and Innate Immune Dysfunction in Older People on Host Interactions With Streptococcus pneumoniae. Front Cell Infect Microbiol 2021;11:651474. [PMID: 34113578 DOI: 10.3389/fcimb.2021.651474] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Fulop T, Larbi A, Hirokawa K, Cohen AA, Witkowski JM. Immunosenescence is both functional/adaptive and dysfunctional/maladaptive. Semin Immunopathol 2020;42:521-36. [PMID: 32930852 DOI: 10.1007/s00281-020-00818-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
8 Sandionigi A, De Giani A, Tursi F, Michelotti A, Cestone E, Giardina S, Zampolli J, Di Gennaro P, Abbassi MS. Effectiveness of Multistrain Probiotic Formulation on Common Infectious Disease Symptoms and Gut Microbiota Modulation in Flu-Vaccinated Healthy Elderly Subjects. BioMed Research International 2022;2022:1-16. [DOI: 10.1155/2022/3860896] [Reference Citation Analysis]
9 Dijkstra JM, Hashimoto K. Expected immune recognition of COVID-19 virus by memory from earlier infections with common coronaviruses in a large part of the world population. F1000Res 2020;9:285. [PMID: 32595955 DOI: 10.12688/f1000research.23458.2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
10 Dimeglio C, Miedougé M, Loubes JM, Mansuy JM, Izopet J. Estimating the impact of public health strategies on the spread of SARS-CoV-2: Epidemiological modelling for Toulouse, France. Rev Med Virol 2021;:e2224. [PMID: 33713504 DOI: 10.1002/rmv.2224] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
11 Howlader DR, Das S, Lu T, Hu G, Varisco DJ, Dietz ZK, Walton SP, Ratnakaram SSK, Gardner FM, Ernst RK, Picking WD, Picking WL. Effect of Two Unique Nanoparticle Formulations on the Efficacy of a Broadly Protective Vaccine Against Pseudomonas Aeruginosa. Front Pharmacol 2021;12:706157. [PMID: 34483911 DOI: 10.3389/fphar.2021.706157] [Reference Citation Analysis]
12 Rocamora-Reverte L, Melzer FL, Würzner R, Weinberger B. The Complex Role of Regulatory T Cells in Immunity and Aging. Front Immunol 2020;11:616949. [PMID: 33584708 DOI: 10.3389/fimmu.2020.616949] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
13 Seymour F, Carmichael J, Taylor C, Parrish C, Cook G. Immune senescence in multiple myeloma-a role for mitochondrial dysfunction? Leukemia 2022. [PMID: 35879358 DOI: 10.1038/s41375-022-01653-7] [Reference Citation Analysis]
14 Voic H, de Vries RD, Sidney J, Rubiro P, Moore E, Phillips E, Mallal S, Schwan B, Weiskopf D, Sette A, Grifoni A. Identification and Characterization of CD4+ T Cell Epitopes after Shingrix Vaccination. J Virol 2020;94:e01641-20. [PMID: 32999027 DOI: 10.1128/JVI.01641-20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
15 Peiris M, Leung GM. What can we expect from first-generation COVID-19 vaccines? Lancet 2020;396:1467-9. [PMID: 32971042 DOI: 10.1016/S0140-6736(20)31976-0] [Cited by in Crossref: 56] [Cited by in F6Publishing: 26] [Article Influence: 28.0] [Reference Citation Analysis]
16 Phillis A. A COVID-19 vaccine—dare to dream. Br J Community Nurs 2020;25:2-7. [DOI: 10.12968/bjcn.2020.25.12.598] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
17 Henn W. Allocation criteria for an initial shortage of a future SARS-CoV-2 vaccine and necessary measures for global immunity. Vaccine 2020;38:5396-7. [PMID: 32600909 DOI: 10.1016/j.vaccine.2020.06.058] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
18 Pereira B, Xu XN, Akbar AN. Targeting Inflammation and Immunosenescence to Improve Vaccine Responses in the Elderly. Front Immunol 2020;11:583019. [PMID: 33178213 DOI: 10.3389/fimmu.2020.583019] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 9.0] [Reference Citation Analysis]
19 Czarnowska A, Tarasiuk J, Zajkowska O, Wnuk M, Marona M, Nowak K, Słowik A, Jamroz-wiśniewska A, Rejdak K, Lech B, Popiel M, Rościszewska-żukowska I, Perenc A, Bartosik-psujek H, Świderek-matysiak M, Siger M, Ciach A, Walczak A, Jurewicz A, Stasiołek M, Kania K, Dyczkowska K, Kalinowska-łyszczarz A, Galus W, Walawska-hrycek A, Krzystanek E, Chojdak-łukasiewicz J, Ubysz J, Pokryszko-dragan A, Kapica-topczewska K, Chorąży M, Bazylewicz M, Mirończuk A, Kulikowska J, Kochanowicz J, Białek M, Stolarz M, Kubicka-bączyk K, Niedziela N, Morawiec N, Adamczyk-sowa M, Podlecka-piętowska A, Nojszewska M, Zakrzewska-pniewska B, Jasińska E, Zaborski J, Milewska-jędrzejczak M, Zwiernik J, Zwiernik B, Potemkowski A, Brola W, Kułakowska A. Safety of Vaccines against SARS-CoV-2 among Polish Patients with Multiple Sclerosis Treated with Disease-Modifying Therapies. Vaccines 2022;10:763. [DOI: 10.3390/vaccines10050763] [Reference Citation Analysis]
20 Hasford J. Large Simple Double-Blind Randomized Trials for the Rapid Assessment of the Effectiveness of COVID-19 Vaccines. J Infect Dis 2020;222:1571-2. [PMID: 32845317 DOI: 10.1093/infdis/jiaa456] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Chung JY, Thone MN, Kwon YJ. COVID-19 vaccines: The status and perspectives in delivery points of view. Adv Drug Deliv Rev 2021;170:1-25. [PMID: 33359141 DOI: 10.1016/j.addr.2020.12.011] [Cited by in Crossref: 138] [Cited by in F6Publishing: 105] [Article Influence: 138.0] [Reference Citation Analysis]
22 Weinberger B. Vaccines and Vaccination against SARS-CoV-2: Considerations for the Older Population. Vaccines (Basel) 2021;9:1435. [PMID: 34960181 DOI: 10.3390/vaccines9121435] [Reference Citation Analysis]
23 Fulop T, Larbi A, Pawelec G, Khalil A, Cohen AA, Hirokawa K, Witkowski JM, Franceschi C. Immunology of Aging: the Birth of Inflammaging. Clin Rev Allergy Immunol 2021. [PMID: 34536213 DOI: 10.1007/s12016-021-08899-6] [Reference Citation Analysis]
24 Hirai T, Yoshioka Y. Considerations of CD8+ T Cells for Optimized Vaccine Strategies Against Respiratory Viruses. Front Immunol 2022;13:918611. [DOI: 10.3389/fimmu.2022.918611] [Reference Citation Analysis]
25 Šterzl I, Absolonová K, Fišerová A. Immune response to vaccination in the elderly. Vnitř Lék 2021;67:E14-8. [DOI: 10.36290/vnl.2021.129] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Batista-Duharte A, Pera A, Aliño SF, Solana R. Regulatory T cells and vaccine effectiveness in older adults. Challenges and prospects. Int Immunopharmacol 2021;96:107761. [PMID: 34162139 DOI: 10.1016/j.intimp.2021.107761] [Reference Citation Analysis]
27 Paramithiotis E, Sugden S, Papp E, Bonhomme M, Chermak T, Crawford SY, Demetriades SZ, Galdos G, Lambert BL, Mattison J, Mcdade T, Pillet S, Murphy R. Cellular Immunity Is Critical for Assessing COVID-19 Vaccine Effectiveness in Immunocompromised Individuals. Front Immunol 2022;13:880784. [DOI: 10.3389/fimmu.2022.880784] [Reference Citation Analysis]
28 Hodgson SH, Mansatta K, Mallett G, Harris V, Emary KRW, Pollard AJ. What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2. Lancet Infect Dis 2021;21:e26-35. [PMID: 33125914 DOI: 10.1016/S1473-3099(20)30773-8] [Cited by in Crossref: 112] [Cited by in F6Publishing: 70] [Article Influence: 56.0] [Reference Citation Analysis]
29 O'Hagan DT, van der Most R, Lodaya RN, Coccia M, Lofano G. "World in motion" - emulsion adjuvants rising to meet the pandemic challenges. NPJ Vaccines 2021;6:158. [PMID: 34934069 DOI: 10.1038/s41541-021-00418-0] [Reference Citation Analysis]
30 Monteiro FR, Roseira T, Amaral JB, Paixão V, Almeida EB, Foster R, Sperandio A, Rossi M, Amirato GR, Apostólico JS, Santos CAF, Felismino ES, Leal FB, Thomazelli LM, Durigon EL, Oliveira DBL, Vieira RP, Santos JMB, Bachi ALL. Combined Exercise Training and l-Glutamine Supplementation Enhances Both Humoral and Cellular Immune Responses after Influenza Virus Vaccination in Elderly Subjects. Vaccines (Basel) 2020;8:E685. [PMID: 33207604 DOI: 10.3390/vaccines8040685] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
31 Costiniuk CT, Singer J, Langlois MA, Kulic I, Needham J, Burchell A, Jenabian MA, Walmsley S, Ostrowski M, Kovacs C, Tan D, Harris M, Hull M, Brumme Z, Brockman M, Margolese S, Mandarino E, Angel JB, Routy JP, Anis AH, Cooper C. CTN 328: immunogenicity outcomes in people living with HIV in Canada following vaccination for COVID-19 (HIV-COV): protocol for an observational cohort study. BMJ Open 2021;11:e054208. [PMID: 34916326 DOI: 10.1136/bmjopen-2021-054208] [Reference Citation Analysis]
32 Yalçın Gürsoy M, Tanrıverdi G, Özsezer G, Chousko Mechmet F. Vaccination coverage and related factors among the elderly: A cross-sectional study from Turkey. Public Health Nurs 2021. [PMID: 34551144 DOI: 10.1111/phn.12972] [Reference Citation Analysis]
33 Stokes AH, Franklin K, Fisher DE, Posobiec LM, Binazon O, Tripathi N, Ringenberg MA, Charlap J, Ziejewski MK, Vemireddi V, Khanna Weiss P, Majumdar R, Bouzya B, Donner MN, Rodriguez LA, Baumeister J. Repeated Dose Toxicity Study and Developmental and Reproductive Toxicology Studies of a Respiratory Syncytial Virus Candidate Vaccine in Rabbits and Rats. Int J Toxicol 2021;40:125-42. [PMID: 33517807 DOI: 10.1177/1091581820985782] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]